Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BREZTRI REGULATORY POST MARKETING SURVEILLANCE IN KOREA

NCT07570394 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07570394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07570394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BREZTRI REGULATORY POST MARKETING SURVEILLANCE IN KOREA
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
September 17, 2026
Completion date
July 31, 2027
Enrollment
600 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, chronic obstructive pulmonary disease (copd)